Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Avidity Biosciences, Inc. - Common Stock (NQ: RNA ) 30.11 -1.01 (-3.25%) Streaming Delayed Price Updated: 4:00 PM EST, Dec 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 1,003,226 Open 30.69 Bid (Size) 28.80 (1) Ask (Size) 30.74 (1) Prev. Close 31.12 Today's Range 29.89 - 31.85 52wk Range 8.860 - 56.00 Shares Outstanding 54,462,518 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News This S&P Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday December 20, 2024 Via Benzinga Topics Stocks Exposures US Equities What 8 Analyst Ratings Have To Say About Avidity Biosciences December 20, 2024 Via Benzinga Performance YTD +228.71% +228.71% 1 Month -30.51% -30.51% 3 Month -28.87% -28.87% 6 Month -26.29% -26.29% 1 Year +222.72% +222.72% More News Read More Avidity Bio Has Surged 416% This Year — And That's Before Today's 'Game-Changing' News November 13, 2024 Via Investor's Business Daily Assessing Avidity Biosciences: Insights From 10 Financial Analysts November 13, 2024 Via Benzinga In-Depth Examination Of 10 Analyst Recommendations For Avidity Biosciences October 21, 2024 Via Benzinga Evaluating Avidity Biosciences: Insights From 10 Financial Analysts October 21, 2024 Via Benzinga Unveiling 7 Analyst Insights On Avidity Biosciences September 16, 2024 Via Benzinga Deep Dive Into Avidity Biosciences Stock: Analyst Perspectives (10 Ratings) August 28, 2024 Via Benzinga The Analyst Landscape: 7 Takes On Avidity Biosciences August 12, 2024 Via Benzinga (RNA) - Analyzing Avidity Biosciences's Short Interest June 20, 2024 Via Benzinga Avidity Biosciences, Up 441%, Nears Another Record High As Dystrophy Space Heats Up October 18, 2024 Via Investor's Business Daily 12 Health Care Stocks Moving In Monday's After-Market Session October 07, 2024 Via Benzinga Why Avidity Biosciences Zoomed to a 12% Gain This Week October 04, 2024 Via The Motley Fool Goldman Sachs Bullish On Avidity Biosciences, Cites Scalable RNA Therapeutics Platform For Rare Diseases September 24, 2024 Via Benzinga Fulcrum Therapeutics Upgraded: BofA Debates Pivotal Study Success For Losmapimod In Rare Genetic Muscle Disease September 09, 2024 Via Benzinga This Early-Stage Biotech Stock Is Up 400% — Should You Buy Now? August 19, 2024 Via MarketBeat RNA Stock Earnings: Avidity Biosciences Beats EPS, Misses Revenue for Q2 2024 August 09, 2024 Via InvestorPlace Expedia Posts Upbeat Earnings, Joins Akamai Technologies, Trade Desk, DXC Technology And Other Big Stocks Moving Higher On Friday August 09, 2024 Via Benzinga How Avidity Biosciences Just Dropped The Hammer On Sarepta Therapeutics August 09, 2024 Via Investor's Business Daily 3 Stocks Doing Even Better Than Superstar Super Micro (SMCI) July 24, 2024 Via InvestorPlace 3 Russell 2000 Growth Stocks That Could Be Worth the Risk July 23, 2024 Via The Motley Fool Topics Economy Exposures Interest Rates GeneDx Leads Russell 2000 This Year As It Shifts To More Comprehensive Genetic Testing July 18, 2024 Via Benzinga Top Performing Industry ETFs In June: Software Leads Returns, Chipmakers Attract Most Inflows July 01, 2024 Via Benzinga Topics ETFs Trading SMID Biotech Stocks In A Volatile Market July 01, 2024 Via Talk Markets Avidity Biosciences And CleanSpark Were Among The 10 Biggest Mid-Cap Stock Gainers Last Week (June 9-June 15): Are These In Your Portfolio? June 16, 2024 Via Benzinga Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
